Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01784588 · ClinicalTrials.gov registry record · NA
Post Market Study Of Single Incision Sling Versus Transobturator Sling for Stress Urinary Incontinence
A NA study, sponsored by Boston Scientific Corporation.
- Completed
- Registry status
- NA
- Development phase
- 281
- Enrollment target
NCT01784588 is a NA study that has completed, run by Boston Scientific Corporation. The registered enrollment target is 281 participants.
The verdict
NCT01784588, a NA study, has completed, sponsored by Boston Scientific Corporation.
- COMPLETED
- Registry status
- NA
- Development phase
- 281 participants
- Enrollment target
Study Summary
The purpose of this research study is to compare the treatment device (Solyx) to a different mesh sling or control device (Obtryx II) for the treatment of symptoms for Stress Urinary Incontinence (SUI). Safety information and patient outcomes will be collected for three (3) years and evaluated.
Interventions
- DEVICE Solyx Single Incision Sling System
- DEVICE Obtryx II Sling System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 281 participants |
| Start Date | 2013-06 |
| Est. Completion | 2018-01-17 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01784588
The ClinicalTrials.gov registry entry for NCT01784588 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 281 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Boston Scientific Corporation, which has 280 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Solyx Single Incision Sling System is the first listed.
NCT01784588 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01784588 about?
NCT01784588 is a clinical study titled "Post Market Study Of Single Incision Sling Versus Transobturator Sling for Stress Urinary Incontinence". The purpose of this research study is to compare the treatment device (Solyx) to a different mesh sling or control device (Obtryx II) for the treatment of symptoms for Stress Urinary Incontinence (SUI). Safety information and patient outcomes will be collected for three (3) years and evaluated.
What is the current status of trial NCT01784588?
This trial is currently completed. It is a NA study. The enrollment target is 281 participants. The study started on 2013-06. Estimated completion is 2018-01-17.
What interventions are being tested in trial NCT01784588?
The interventions under investigation include: Solyx Single Incision Sling System (DEVICE), Obtryx II Sling System (DEVICE).
Who is sponsoring clinical trial NCT01784588?
This trial is sponsored by Boston Scientific Corporation, which has 280 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.